Hoya Group Invests in SalutarisMD Wet AMD Therapy Technology 

HOYA Group has closed financing in Salutaris Medical Devices (SalutarisMD®). SalutarisMD will use the funding to further its growth strategy in developing its patented medical device designed for minimally invasive therapy of wet age-related macular degeneration (wet AMD). Wet AMD is a leading cause of vision loss and blindness that primarily affects older adults.

Continue reading